RecruitingNCT06355414
Psilocybin in Chronic Low Back Pain and Depression
Official study title
In BaltimorePsilocybin and Affective Function in Chronic Lower Back Pain Depression
DepressionMedication studyAges 21–80
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
RecruitingNCT07226232
Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
Official study title
Multiple locations, including BirminghamA Multi-site Randomized Controlled Trial of Psilocybin for Treatment-Resistant Depression (TRD) in Veterans
DepressionMedication studyAges 18–75
RecruitingNCT07183748
Psilocybin Microdosing With Psychotherapy for Treatment-Resistant Depression
What is this study about?
In BeershebaThis study evaluates the safety and effectiveness of psychotherapy for people with depression.
DepressionMedication studyAges 18–65
RecruitingNCT06810310
Psilocybin on Brain Mechanisms of Motivation in OUD
Official study title
In PhiladelphiaPsilocybin: Capturing Brain Mechanisms of Motivation and Neurocognition in Individuals With Opioid Use Disorder
AddictionMedication studyAges 18–60
RecruitingNCT06405607
Psilocybin or Ketamine for Addiction: An Active Comparator study
Official study title
In Iowa CityPsilocybin vs Ketamine for Alcohol Use Disorder
AddictionMedication studyAges 21–65
RecruitingNCT06132178
Psilocybin rTMS for Treatment Resistant Depression
What is this study about?
In AustinThis study evaluates the safety and effectiveness of Psilocybin for people with depression.
DepressionMedication studyAges 22–65
RecruitingNCT06455293
Psilocybin Therapy for Depression in Parkinson's Disease
What is this study about?
In San FranciscoThis study evaluates the effectiveness of Psilocybin for people with depression.
DepressionMedication studyAges 40–80
RecruitingNCT06782724
Psilocybin Therapy for Psychological Distress in Palliative Patients
Official study title
Multiple locations, including PragueThe Safety and Efficacy of Psilocybin Therapy Compared to Low-dose Control in Reducing Depressive Symptoms in Patients With COPD, ALS, MS, or APD.
DepressionMedication studyAges 18+
RecruitingNCT07251491
Psilocybin to Treat Depression in Spinal Cord Injury
Official study title
In The BronxSafety, Tolerability, Outcomes of Psilocybin for Depression (STOP Depression) in Veterans With Spinal Cord Injury
DepressionMedication studyAges 22+
RecruitingNCT07347405
Psilocybin Whole Mushroom for OCD.
What is this study about?
In TucsonResearchers are comparing Psilocybin 10 mg, Psilocybin 20 mg and Psilocybin 30 mg to find out how the approaches affect obsessive thoughts and compulsive behaviours in people with OCD.
OCDMedication studyAges 18+
RecruitingNCT06592833
Psilocybin With Pimavanserin Compared to Psilocybin Alone for Major Depressive Disorder
Official study title
In New YorkInvestigating the Role of Serotonin in the Mechanism of Action of Psilocybin in Patients With Major Depressive Disorder
DepressionMedication studyAges 21–80
RecruitingNCT05995769
Psilocybin-Assisted Psychotherapy for Addiction
Official study title
In CalgaryMechanisms Supporting Psilocybin-assisted Psychotherapy for Alcohol Use Disorder: A Randomized, Controlled Clinical Trial
AddictionMedication studyAges 22–65
Registry coverage
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.